|
1
|
Alexander M, Kim SY and Cheng H: Update
2020: Management of non-small cell lung cancer. Lung. 198:897–907.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wu F, Fan J, He Y, Xiong A, Yu J, Li Y,
Zhang Y, Zhao W, Zhou F, Li W, et al: Single-cell profiling of
tumor heterogeneity and the microenvironment in advanced non-small
cell lung cancer. Nat Commun. 12(2540)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shinohara S, Takahashi Y, Komuro H, Matsui
T, Sugita Y, Demachi-Okamura A, Muraoka D, Takahara H, Nakada T,
Sakakura N, et al: New evaluation of the tumor immune
microenvironment of non-small cell lung cancer and its association
with prognosis. J Immunother Cancer. 10(e003765)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sun X, Chen P, Chen X, Yang W, Chen X,
Zhou W, Huang D and Cheng Y: KIF4A enhanced cell proliferation and
migration via Hippo signaling and predicted a poor prognosis in
esophageal squamous cell carcinoma. Thorac Cancer. 12:512–524.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Injinari N, Amini-Farsani Z,
Yadollahi-Farsani M and Teimori H: Apoptotic effects of valproic
acid on miR-34a, miR-520h and HDAC1 gene in breast cancer. Life
Sci. 269(119027)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Thangaraju M, Carswell KN, Prasad PD and
Ganapathy V: Colon cancer cells maintain low levels of pyruvate to
avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J.
417:379–389. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu S, Wu E, Wang D, Niu Y, Yue H, Zhang D,
Luo J and Chen R: LncRNA HRCEG, regulated by HDAC1, inhibits cells
proliferation and epithelial-mesenchymal-transition in gastric
cancer. Cancer Genet. 241:25–33. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Aghdassi A, Sendler M, Guenther A, Mayerle
J, Behn CO, Heidecke CD, Friess H, Büchler M, Evert M, Lerch MM and
Weiss FU: Recruitment of histone deacetylases HDAC1 and HDAC2 by
the transcriptional repressor ZEB1 downregulates E-cadherin
expression in pancreatic cancer. Gut. 61:439–448. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang Y, Nalawansha DA, Herath KE, Andrade
R and Pflum MKH: Differential profiles of HDAC1 substrates and
associated proteins in breast cancer cells revealed by trapping.
Mol Omics. 17:544–553. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Banerjee A, Mahata B, Dhir A, Mandal TK
and Biswas K: Elevated histone H3 acetylation and loss of the
Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell
carcinoma. J Biol Chem. 294:1005–1018. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Huang R, Zhang X, Sophia S, Min Z and Liu
X: Clinicopathological features and prediction values of HDAC1,
HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma. Anticancer
Drugs. 29:364–370. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang L, Bu L, Hu J, Xu Z, Ruan L, Fang Y
and Wang P: HDAC1 knockdown inhibits invasion and induces apoptosis
in non-small cell lung cancer cells. Biol Chem. 399:603–610.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jiang C, Liao J, Yang F, Jiang T, Zhang D
and Xin Y: The potential mechanism of HDAC1-Catalyzed histone
crotonylation of Caspase-1 in nonsmall cell lung cancer. Evid Based
Complement Alternat Med. 2022(5049116)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing miRNA-LncRNA Interactions. Methods Mol Biol.
1402:271–286. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang Y and Tang L: The Application of
lncRNAs in cancer treatment and diagnosis. Recent Pat Anticancer
Drug Discov. 13:292–301. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Qi HL, Li CS, Qian CW, Xiao YS, Yuan YF,
Liu QY and Liu ZS: The long noncoding RNA, EGFR-AS1, a target of
GHR, increases the expression of EGFR in hepatocellular carcinoma.
Tumour Biol. 37:1079–1089. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xue Y, Zhang J, Hou J and Wang X: EGFR-AS1
promotes nonsmall cell lung cancer (NSCLC) progression via
downregulating the miR-524-5p/DRAM1 axis and inhibiting autophagic
lysosomal degradation. J Oncol. 2022(4402536)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Re M, Tomasetti M, Monaco F, Amati M,
Rubini C, Sollini G, Bajraktari A, Gioacchini FM, Santarelli L and
Pasquini E: MiRNome analysis identifying miR-205 and miR-449a as
biomarkers of disease progression in intestinal-type sinonasal
adenocarcinoma. Head Neck. 44:18–33. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer.
10(29)2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Luo W, Huang B, Li Z, Li H, Sun L, Zhang
Q, Qiu X and Wang E: MicroRNA-449a is downregulated in non-small
cell lung cancer and inhibits migration and invasion by targeting
c-Met. PLoS One. 8(e64759)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jiang J, Yang X, He X, Ma W, Wang J, Zhou
Q, Li M and Yu S: MicroRNA-449b-5p suppresses the growth and
invasion of breast cancer cells via inhibiting CREPT-mediated
Wnt/DDD-catenin signaling. Chem Biol Interact. 302:74–82.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tabibkhooei A, Izadpanahi M, Arab A,
Zare-Mirzaei A, Minaeian S, Rostami A and Mohsenian A: Profiling of
novel circulating microRNAs as a non-invasive biomarker in
diagnosis and follow-up of high and low-grade gliomas. Clin Neurol
Neurosurg. 190(105652)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Buurman R, Gürlevik E, Schäffer V, Eilers
M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and
Skawran B: Histone deacetylases activate hepatocyte growth factor
signaling by repressing microRNA-449 in hepatocellular carcinoma
cells. Gastroenterology. 143:811–820.e15. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yuan JM, Shi XJ, Sun P, Liu JX, Wang W, Li
M and Ling FY: Downregulation of cell cycle-related proteins in
ovarian cancer line and cell cycle arrest induced by microRNA. Int
J Clin Exp Med. 8:18476–18481. 2015.PubMed/NCBI
|
|
28
|
Yong-Ming H, Ai-Jun J, Xiao-Yue X,
Jian-Wei L, Chen Y and Ye C: miR-449a: A potential therapeutic
agent for cancer. Anticancer Drugs. 28:1067–1078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jang SG, Yoo CW, Park SY, Kang S and Kim
HK: Low expression of miR-449 in gynecologic clear cell carcinoma.
Int J Gynecol Cancer. 24:1558–1563. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gupta S, Silveira DA and Mombach JCM:
Modeling the role of microRNA-449a in the regulation of the G2/M
cell cycle checkpoint in prostate LNCaP cells under ionizing
radiation. PLoS One. 13(e0200768)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42 (Database issue):D92–D97. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Karginov FV and Hannon GJ: Remodeling of
Ago2-mRNA interactions upon cellular stress reflects miRNA
complementarity and correlates with altered translation rates.
Genes Dev. 27:1624–1632. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gao S, Gang J, Yu M, Xin G and Tan H:
Computational analysis for identification of early diagnostic
biomarkers and prognostic biomarkers of liver cancer based on GEO
and TCGA databases and studies on pathways and biological functions
affecting the survival time of liver cancer. BMC Cancer.
21(791)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ginn L, Shi L, Montagna M and Garofalo M:
LncRNAs in Non-Small-cell lung cancer. Noncoding RNA.
6(25)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hu J, Qian Y, Peng L, Ma L, Qiu T, Liu Y,
Li X and Chen X: Long Noncoding RNA EGFR-AS1 promotes cell
proliferation by increasing EGFR mRNA stability in gastric cancer.
Cell Physiol Biochem. 49:322–334. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yuan S, Luan X, Chen H, Shi X and Zhang X:
Long non-coding RNA EGFR-AS1 sponges micorRNA-381 to upregulate
ROCK2 in bladder cancer. Oncol Lett. 19:1899–1905. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lee SS and Cheah YK: The Interplay between
MicroRNAs and cellular components of tumour microenvironment (TME)
on Non-small-cell lung cancer (NSCLC) progression. J Immunol Res.
2019(3046379)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yi M, Liao Z, Deng L, Xu L, Tan Y, Liu K,
Chen Z and Zhang Y: High diagnostic value of miRNAs for NSCLC:
Quantitative analysis for both single and combined miRNAs in lung
cancer. Ann Med. 53:2178–2193. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liang G, Meng W, Huang X, Zhu W, Yin C,
Wang C, Fassan M, Yu Y, Kudo M, Xiao S, et al: miR-196b-5p-mediated
downregulation of TSPAN12 and GATA6 promotes tumor progression in
non-small cell lung cancer. Proc Natl Acad Sci USA. 117:4347–4357.
2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Toh TB, Lim JJ and Chow EK: Epigenetics in
cancer stem cells. Mol Cancer. 16(29)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lu S, Chen Z and Liu Z and Liu Z:
Unmasking the biological function and regulatory mechanism of
NOC2L: A novel inhibitor of histone acetyltransferase. J Transl
Med. 21(31)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gao S, Tan H and Li D: Oridonin suppresses
gastric cancer SGC-7901 cell proliferation by targeting the
TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. J
Cell Mol Med. 27:2661–2674. 2023.PubMed/NCBI View Article : Google Scholar
|
